EGFR and hepatocellular carcinoma: During the treatment, the expression of HNF4A, MAPK8, NR3C1, PTEN, EGFR, and HDAC1 was regulated by KXYA, indicating their important roles during the tumorigenesis and progression of HBV-related HCC and might be the targets for the clinical diagnosis and therapy.